![FHZ FHZ](https://data.pdbj.org/pdbjplus/data/cc/svg/FHZ.svg) | FHZ | Name: | (2~{R})-3-(4-methoxyphenyl)-2-(2~{H}-1,2,3,4-tetrazol-5-yl)propanehydrazide | Formula: | C11 H14 N6 O2 | SMILES: | COc1ccc(C[CH](C(=O)NN)c2n[nH]nn2)cc1 | InChi: | InChI=1S/C11H14N6O2/c1-19-8-4-2-7(3-5-8)6-9(11(18)13-12)10-14-16-17-15-10/h2-5,9H,6,12H2,1H3,(H,13,18)(H,14,15,16,17)/t9-/m1/s1 | Definition date: | 2018-07-10 | Last modified: | 2020-01-24 | Release date: | 2020-01-29 | Identifier: | (2~{R})-3-(4-methoxyphenyl)-2-(2~{H}-1,2,3,4-tetrazol-5-yl)propanehydrazide |
|
![JY1 JY1](https://data.pdbj.org/pdbjplus/data/cc/svg/JY1.svg) | JY1 | Name: | bis[diethyl(methyl)-lambda~5~-phosphanyl]{bis[{[(2-{[2-(2,5-dioxopyrrolidin-1-yl)ethyl]amino}-2-oxoethyl)amino]methyl}(diethyl)-lambda~5~-phosphanyl]}rhodium | Formula: | C36 H74 N6 O6 P4 Rh | SMILES: | C(C)P(CC)(CNCC(NCCN1C(CCC1=O)=O)=O)[Rh](P(CC)(CC)C)(P(CC)(CC)CNCC(NCCN2C(CCC2=O)=O)=O)P(C)(CC)CC | InChi: | InChI=1S/2C13H24N3O3P.2C5H13P.Rh/c2*1-3-20(4-2)10-14-9-11(17)15-7-8-16-12(18)5-6-13(16)19 | Definition date: | 2018-10-16 | Last modified: | 2020-01-18 | Release date: | 2019-02-06 | Identifier: | bis[diethyl(methyl)-lambda~5~-phosphanyl]{bis[{[(2-{[2-(2,5-dioxopyrrolidin-1-yl)ethyl]amino}-2-oxoethyl)amino]methyl}(diethyl)-lambda~5~-phosphanyl]}rhodium (non-preferred name) |
|
![KUD KUD](https://data.pdbj.org/pdbjplus/data/cc/svg/KUD.svg) | KUD | Name: | [(1S,2R)-2-(benzenecarbonyl)cyclopentyl]acetic acid | Formula: | C14 H16 O3 | SMILES: | C2CCC(C(=O)c1ccccc1)C2CC(O)=O | InChi: | InChI=1S/C14H16O3/c15-13(16)9-11-7-4-8-12(11)14(17)10-5-2-1-3-6-10/h1-3,5-6,11-12H,4,7-9H2,(H,15,16)/t11-,12+/m0/s1 | Definition date: | 2019-01-16 | Last modified: | 2020-01-17 | Release date: | 2020-01-22 | Identifier: | [(1S,2R)-2-(benzenecarbonyl)cyclopentyl]acetic acid |
|
![KUG KUG](https://data.pdbj.org/pdbjplus/data/cc/svg/KUG.svg) | KUG | Name: | [(1R,2S)-2-(benzenecarbonyl)cyclopentyl]acetic acid | Formula: | C14 H16 O3 | SMILES: | C2CCC(C(c1ccccc1)=O)C2CC(O)=O | InChi: | InChI=1S/C14H16O3/c15-13(16)9-11-7-4-8-12(11)14(17)10-5-2-1-3-6-10/h1-3,5-6,11-12H,4,7-9H2,(H,15,16)/t11-,12+/m1/s1 | Definition date: | 2019-01-16 | Last modified: | 2020-01-17 | Release date: | 2020-01-22 | Identifier: | [(1R,2S)-2-(benzenecarbonyl)cyclopentyl]acetic acid |
|
![KXG KXG](https://data.pdbj.org/pdbjplus/data/cc/svg/KXG.svg) | KXG | Name: | [[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] [(3~{S},4~{R},5~{R})-3,4-bis(oxidanyl)-5-sulfanyl-oxolan-2-yl]methyl hydrogen phosphate | Formula: | C15 H23 N5 O13 P2 S | SMILES: | C2(C(C(C(COP(=O)(O)OP(=O)(O)OCC1C(C(C(O1)S)O)O)O2)O)O)n4c3c(c(ncn3)N)nc4 | InChi: | InChI=1S/C15H23N5O13P2S/c16-12-7-13(18-3-17-12)20(4-19-7)14-10(23)8(21)5(31-14)1-29-34(25,26)33-35(27,28)30-2-6-9(22)11(24)15(36)32-6/h3-6,8-11,14-15,21-24,36H,1-2H2,(H,25,26)(H,27,28)(H2,16,17,18)/t5-,6-,8-,9-,10-,11-,14-,15-/m1/s1 | Definition date: | 2019-01-23 | Last modified: | 2020-01-17 | Release date: | 2020-01-22 | Identifier: | [(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl [(2R,3S,4R,5R)-3,4-dihydroxy-5-sulfanyltetrahydrofuran-2-yl]methyl dihydrogen diphosphate (non-preferred name) |
|
![KXJ KXJ](https://data.pdbj.org/pdbjplus/data/cc/svg/KXJ.svg) | KXJ | Name: | N~2~-[3-(2-hydroxyethoxy)propanoyl]-N-phenyl-N~6~-tetradecanethioyl-L-lysinamide | Formula: | C31 H53 N3 O4 S | SMILES: | C(Nc1ccccc1)(=O)C(CCCCNC(CCCCCCCCCCCCC)=S)NC(=O)CCOCCO | InChi: | InChI=1S/C31H53N3O4S/c1-2-3-4-5-6-7-8-9-10-11-15-21-30(39)32-23-17-16-20-28(34-29(36)22-25-38-26-24-35)31(37)33-27-18-13-12-14-19-27/h12-14,18-19,28,35H,2-11,15-17,20-26H2,1H3,(H,32,39)(H,33,37)(H,34,36)/t28-/m0/s1 | Definition date: | 2019-01-23 | Last modified: | 2020-01-17 | Release date: | 2020-01-22 | Identifier: | N~2~-[3-(2-hydroxyethoxy)propanoyl]-N-phenyl-N~6~-tetradecanethioyl-L-lysinamide |
|
![KJT KJT](https://data.pdbj.org/pdbjplus/data/cc/svg/KJT.svg) | KJT | Name: | diethyl-[6-[[2-[2-[2-[naphthalen-2-ylsulfonyl-[[(3~{R})-1-(phenylmethyl)piperidin-3-yl]methyl]amino]ethoxy]ethoxy]ethylamino]-oxidanyl-methyl]-7-oxidanylidene-1,3,4,4~{a},5,6,8,8~{a}-octahydronaphthalen-2-ylidene]azanium | Formula: | C44 H63 N4 O6 S | SMILES: | CC[N+](CC)=C1CCC2CC(C(O)NCCOCCOCCN(C[CH]3CCCN(C3)Cc4ccccc4)[S](=O)(=O)c5ccc6ccccc6c5)C(=O)CC2C1 | InChi: | InChI=1S/C44H63N4O6S/c1-3-47(4-2)40-18-16-38-29-42(43(49)30-39(38)27-40)44(50)45-20-23-53-25-26-54-24-22-48(55(51,52)41-19-17-36-14-8-9-15-37(36)28-41)33-35-13-10-21-46(32-35)31-34-11-6-5-7-12-34/h5-9,11-12,14-15,17,19,28,35,38-39,42,44-45,50H,3-4,10,13,16,18,20-27,29-33H2,1-2H3/q+1/t35-,38?,39?,42?,44?/m1/s1 | Definition date: | 2019-05-28 | Last modified: | 2020-01-17 | Release date: | 2020-01-22 | Identifier: | diethyl-[6-[[2-[2-[2-[naphthalen-2-ylsulfonyl-[[(3~{R})-1-(phenylmethyl)piperidin-3-yl]methyl]amino]ethoxy]ethoxy]ethylamino]-oxidanyl-methyl]-7-oxidanylidene-1,3,4,4~{a},5,6,8,8~{a}-octahydronaphthalen-2-ylidene]azanium |
|
![N72 N72](https://data.pdbj.org/pdbjplus/data/cc/svg/N72.svg) | N72 | Name: | (2~{R})-2-[[(3~{R},4~{R},5~{S})-3,4,5,6-tetrakis(oxidanyl)-2-oxidanylidene-hexyl]amino]pentanedioic acid | Formula: | C11 H19 N O9 | SMILES: | OC[CH](O)[CH](O)[CH](O)C(=O)CN[CH](CCC(O)=O)C(O)=O | InChi: | InChI=1S/C11H19NO9/c13-4-7(15)10(19)9(18)6(14)3-12-5(11(20)21)1-2-8(16)17/h5,7,9-10,12-13,15,18-19H,1-4H2,(H,16,17)(H,20,21)/t5-,7+,9+,10-/m1/s1 | Definition date: | 2019-11-14 | Last modified: | 2020-01-17 | Release date: | 2020-01-22 | Identifier: | (2~{R})-2-[[(3~{R},4~{R},5~{S})-3,4,5,6-tetrakis(oxidanyl)-2-oxidanylidene-hexyl]amino]pentanedioic acid |
|
![N7T N7T](https://data.pdbj.org/pdbjplus/data/cc/svg/N7T.svg) | N7T | Name: | (2~{S})-2-[[(3~{S},4~{R},5~{R})-3,4,5,6-tetrakis(oxidanyl)-2-oxidanylidene-hexyl]amino]pentanedioic acid | Formula: | C11 H19 N O9 | SMILES: | OC[CH](O)[CH](O)[CH](O)C(=O)CN[CH](CCC(O)=O)C(O)=O | InChi: | InChI=1S/C11H19NO9/c13-4-7(15)10(19)9(18)6(14)3-12-5(11(20)21)1-2-8(16)17/h5,7,9-10,12-13,15,18-19H,1-4H2,(H,16,17)(H,20,21)/t5-,7+,9+,10+/m0/s1 | Definition date: | 2019-11-14 | Last modified: | 2020-01-17 | Release date: | 2020-01-22 | Identifier: | (2~{S})-2-[[(3~{S},4~{R},5~{R})-3,4,5,6-tetrakis(oxidanyl)-2-oxidanylidene-hexyl]amino]pentanedioic acid |
|
![M2E M2E](https://data.pdbj.org/pdbjplus/data/cc/svg/M2E.svg) | M2E | Name: | (4-chlorophenyl)-[(3~{S})-3-oxidanylpiperidin-1-yl]methanone | Formula: | C12 H14 Cl N O2 | SMILES: | O[CH]1CCCN(C1)C(=O)c2ccc(Cl)cc2 | InChi: | InChI=1S/C12H14ClNO2/c13-10-5-3-9(4-6-10)12(16)14-7-1-2-11(15)8-14/h3-6,11,15H,1-2,7-8H2/t11-/m0/s1 | Definition date: | 2019-10-02 | Last modified: | 2020-01-17 | Release date: | 2020-01-22 | Identifier: | (4-chlorophenyl)-[(3~{S})-3-oxidanylpiperidin-1-yl]methanone |
|
![M2H M2H](https://data.pdbj.org/pdbjplus/data/cc/svg/M2H.svg) | M2H | Name: | 3,5-dimethyl-1~{H}-pyrrole-2-carbonitrile | Formula: | C7 H8 N2 | SMILES: | Cc1[nH]c(C#N)c(C)c1 | InChi: | InChI=1S/C7H8N2/c1-5-3-6(2)9-7(5)4-8/h3,9H,1-2H3 | Definition date: | 2019-10-02 | Last modified: | 2020-01-17 | Release date: | 2020-01-22 | Identifier: | 3,5-dimethyl-1~{H}-pyrrole-2-carbonitrile |
|
![M2K M2K](https://data.pdbj.org/pdbjplus/data/cc/svg/M2K.svg) | M2K | Name: | 4,5,6,7-tetrahydro-2~{H}-indazole-3-carboxylic acid | Formula: | C8 H10 N2 O2 | SMILES: | OC(=O)c1[nH]nc2CCCCc12 | InChi: | InChI=1S/C8H10N2O2/c11-8(12)7-5-3-1-2-4-6(5)9-10-7/h1-4H2,(H,9,10)(H,11,12) | Definition date: | 2019-10-02 | Last modified: | 2020-01-17 | Release date: | 2020-01-22 | Identifier: | 4,5,6,7-tetrahydro-2~{H}-indazole-3-carboxylic acid |
|
![JPE JPE](https://data.pdbj.org/pdbjplus/data/cc/svg/JPE.svg) | JPE | Name: | [(2~{R},3~{S},4~{R},5~{R})-5-(6-azanyl-2-pyridin-3-yl-purin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl ~{N}-[(2~{S})-2-azanyl-3-oxidanyl-propanoyl]sulfamate | Formula: | C18 H22 N8 O8 S | SMILES: | N[CH](CO)C(=O)N[S](=O)(=O)OC[CH]1O[CH]([CH](O)[CH]1O)n2cnc3c(N)nc(nc23)c4cccnc4 | InChi: | InChI=1S/C18H22N8O8S/c19-9(5-27)17(30)25-35(31,32)33-6-10-12(28)13(29)18(34-10)26-7-22-11-14(20)23-15(24-16(11)26)8-2-1-3-21-4-8/h1-4,7,9-10,12-13,18,27-29H,5-6,19H2,(H,25,30)(H2,20,23,24)/t9-,10+,12+,13+,18+/m0/s1 | Definition date: | 2019-03-14 | Last modified: | 2020-01-17 | Release date: | 2020-01-22 | Identifier: | [(2~{R},3~{S},4~{R},5~{R})-5-(6-azanyl-2-pyridin-3-yl-purin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl ~{N}-[(2~{S})-2-azanyl-3-oxidanyl-propanoyl]sulfamate |
|
![JPT JPT](https://data.pdbj.org/pdbjplus/data/cc/svg/JPT.svg) | JPT | Name: | 6-(hydroxymethyl)-3-oxidanyl-2-(thiophen-3-ylmethyl)pyran-4-one | Formula: | C11 H10 O4 S | SMILES: | OCC1=CC(=O)C(=C(Cc2cscc2)O1)O | InChi: | InChI=1S/C11H10O4S/c12-5-8-4-9(13)11(14)10(15-8)3-7-1-2-16-6-7/h1-2,4,6,12,14H,3,5H2 | Definition date: | 2019-03-15 | Last modified: | 2020-01-17 | Release date: | 2020-01-22 | Identifier: | 6-(hydroxymethyl)-3-oxidanyl-2-(thiophen-3-ylmethyl)pyran-4-one |
|
![AQ6 AQ6](https://data.pdbj.org/pdbjplus/data/cc/svg/AQ6.svg) | AQ6 | Name: | 4-[[4-azanyl-3-(4-cyclohexylpiperazin-1-yl)-9,10-bis(oxidanylidene)anthracen-1-yl]amino]benzoic acid | Formula: | C31 H32 N4 O4 | SMILES: | Nc1c(cc(Nc2ccc(cc2)C(O)=O)c3C(=O)c4ccccc4C(=O)c13)N5CCN(CC5)C6CCCCC6 | InChi: | InChI=1S/C31H32N4O4/c32-28-25(35-16-14-34(15-17-35)21-6-2-1-3-7-21)18-24(33-20-12-10-19(11-13-20)31(38)39)26-27(28)30(37)23-9-5-4-8-22(23)29(26)36/h4-5,8-13,18,21,33H,1-3,6-7,14-17,32H2,(H,38,39) | Definition date: | 2018-11-15 | Last modified: | 2020-01-17 | Release date: | 2020-01-22 | Identifier: | 4-[[4-azanyl-3-(4-cyclohexylpiperazin-1-yl)-9,10-bis(oxidanylidene)anthracen-1-yl]amino]benzoic acid |
|
![BS6 BS6](https://data.pdbj.org/pdbjplus/data/cc/svg/BS6.svg) | BS6 | Name: | 2-methoxy-N-[2-methyl-6-(4-methylpiperazin-1-yl)-3-oxidanylidene-2,7-diazatricyclo[6.3.1.0^{4,12}]dodeca-1(12),4,6,8,10-pentaen-9-yl]benzenesulfonamide | Formula: | C23 H25 N5 O4 S | SMILES: | COc1ccccc1[S](=O)(=O)Nc2ccc3N(C)C(=O)c4cc(nc2c34)N5CCN(C)CC5 | InChi: | InChI=1S/C23H25N5O4S/c1-26-10-12-28(13-11-26)20-14-15-21-17(27(2)23(15)29)9-8-16(22(21)24-20)25-33(30,31)19-7-5-4-6-18(19)32-3/h4-9,14,25H,10-13H2,1-3H3 | Definition date: | 2019-03-06 | Last modified: | 2020-01-17 | Release date: | 2020-01-22 | Identifier: | 2-methoxy-~{N}-[2-methyl-6-(4-methylpiperazin-1-yl)-3-oxidanylidene-2,7-diazatricyclo[6.3.1.0^{4,12}]dodeca-1(12),4,6,8,10-pentaen-9-yl]benzenesulfonamide |
|
![BT0 BT0](https://data.pdbj.org/pdbjplus/data/cc/svg/BT0.svg) | BT0 | Name: | 2-methoxy-N-(1-methyl-2-oxidanylidene-benzo[cd]indol-6-yl)benzenesulfonamide | Formula: | C19 H16 N2 O4 S | SMILES: | COc1ccccc1[S](=O)(=O)Nc2ccc3N(C)C(=O)c4cccc2c34 | InChi: | InChI=1S/C19H16N2O4S/c1-21-15-11-10-14(12-6-5-7-13(18(12)15)19(21)22)20-26(23,24)17-9-4-3-8-16(17)25-2/h3-11,20H,1-2H3 | Definition date: | 2019-03-07 | Last modified: | 2020-01-17 | Release date: | 2020-01-22 | Identifier: | 2-methoxy-~{N}-(1-methyl-2-oxidanylidene-benzo[cd]indol-6-yl)benzenesulfonamide |
|
![OZ4 OZ4](https://data.pdbj.org/pdbjplus/data/cc/svg/OZ4.svg) | OZ4 | Name: | (7aS,12S,12aR,13aS)-3,3,12,14,14-pentamethyl-3,7,11,12,13,13a,14,15-octahydro-8H,10H-7a,12a-(epiminomethano)indolizino[6,7-h]pyrano[3,2-a]carbazol-16-one | Formula: | C27 H33 N3 O2 | SMILES: | C421C(C)CCN1CC3(NC2=O)Cc5c(C(C3C4)(C)C)nc6c5ccc7OC(C=Cc67)(C)C | InChi: | InChI=1S/C27H33N3O2/c1-15-9-11-30-14-26-12-18-16-6-7-19-17(8-10-24(2,3)32-19)21(16)28-22(18)25(4,5)20(26)13-27(15,30)23(31)29-26/h6-8,10,15,20,28H,9,11-14H2,1-5H3,(H,29,31)/t15-,20-,26+,27+/m0/s1 | Definition date: | 2019-07-22 | Last modified: | 2020-01-17 | Release date: | 2020-01-22 | Identifier: | (7aS,12S,12aR,13aS)-3,3,12,14,14-pentamethyl-3,7,11,12,13,13a,14,15-octahydro-8H,10H-7a,12a-(epiminomethano)indolizino[6,7-h]pyrano[3,2-a]carbazol-16-one |
|
![OZ7 OZ7](https://data.pdbj.org/pdbjplus/data/cc/svg/OZ7.svg) | OZ7 | Name: | (8aS,13S,13aR,14aS)-4,4,13,15,15-pentamethyl-12,13,14,14a,15,16-hexahydro-4H,8H,9H,11H-8a,13a-(epiminomethano)[1,4]dioxepino[2,3-a]indolizino[6,7-h]carbazol-17-one | Formula: | C27 H33 N3 O3 | SMILES: | C127C(CCN1CC6(NC2=O)Cc5c3c(c4OC=CC(C)(C)Oc4cc3)nc5C(C)(C)C6C7)C | InChi: | InChI=1S/C27H33N3O3/c1-15-8-10-30-14-26-12-17-16-6-7-18-21(32-11-9-24(2,3)33-18)20(16)28-22(17)25(4,5)19(26)13-27(15,30)23(31)29-26/h6-7,9,11,15,19,28H,8,10,12-14H2,1-5H3,(H,29,31)/t15-,19-,26+,27+/m0/s1 | Definition date: | 2019-07-22 | Last modified: | 2020-01-17 | Release date: | 2020-01-22 | Identifier: | (8aS,13S,13aR,14aS)-4,4,13,15,15-pentamethyl-12,13,14,14a,15,16-hexahydro-4H,8H,9H,11H-8a,13a-(epiminomethano)[1,4]dioxepino[2,3-a]indolizino[6,7-h]carbazol-17-one |
|
![OZA OZA](https://data.pdbj.org/pdbjplus/data/cc/svg/OZA.svg) | OZA | Name: | (5aS,12aS,13aS)-9-bromo-12,12-dimethyl-2,3,11,12,12a,13-hexahydro-1H,5H,6H-5a,13a-(epiminomethano)indolizino[7,6-b]carbazol-14-one | Formula: | C21 H24 Br N3 O | SMILES: | C314NC(C2(CCCN2C1)CC3C(c5c(C4)c6c(n5)cc(cc6)Br)(C)C)=O | InChi: | InChI=1S/C21H24BrN3O/c1-19(2)16-10-21-6-3-7-25(21)11-20(16,24-18(21)26)9-14-13-5-4-12(22)8-15(13)23-17(14)19/h4-5,8,16,23H,3,6-7,9-11H2,1-2H3,(H,24,26)/t16-,20+,21-/m0/s1 | Definition date: | 2019-07-22 | Last modified: | 2020-01-17 | Release date: | 2020-01-22 | Identifier: | (5aS,12aS,13aS)-9-bromo-12,12-dimethyl-2,3,11,12,12a,13-hexahydro-1H,5H,6H-5a,13a-(epiminomethano)indolizino[7,6-b]carbazol-14-one |
|
![8D0 8D0](https://data.pdbj.org/pdbjplus/data/cc/svg/8D0.svg) | 8D0 | Name: | (6~{a}~{R},9~{R},10~{a}~{R})-9-(hydroxymethyl)-3-(8-isothiocyanato-2-methyl-octan-2-yl)-6,6-dimethyl-6~{a},7,8,9,10,10~{a}-hexahydrobenzo[c]chromen-1-ol | Formula: | C26 H39 N O3 S | SMILES: | CC(C)(CCCCCCN=C=S)c1cc(O)c2[CH]3C[CH](CO)CC[CH]3C(C)(C)Oc2c1 | InChi: | InChI=1S/C26H39NO3S/c1-25(2,11-7-5-6-8-12-27-17-31)19-14-22(29)24-20-13-18(16-28)9-10-21(20)26(3,4)30-23(24)15-19/h14-15,18,20-21,28-29H,5-13,16H2,1-4H3/t18-,20-,21-/m1/s1 | Definition date: | 2017-06-12 | Last modified: | 2020-01-16 | Release date: | 2017-07-12 | Identifier: | (6~{a}~{R},9~{R},10~{a}~{R})-9-(hydroxymethyl)-3-(8-isothiocyanato-2-methyl-octan-2-yl)-6,6-dimethyl-6~{a},7,8,9,10,10~{a}-hexahydrobenzo[c]chromen-1-ol |
|
![HMW HMW](https://data.pdbj.org/pdbjplus/data/cc/svg/HMW.svg) | HMW | Name: | 3-[[4-imidazol-1-yl-6-[(3~{R})-3-oxidanylpyrrolidin-1-yl]-1,3,5-triazin-2-yl]amino]-4-methyl-~{N}-[3-(trifluoromethyl)phenyl]benzamide | Formula: | C25 H23 F3 N8 O2 | SMILES: | Cc1ccc(cc1Nc2nc(nc(n2)n3ccnc3)N4CC[CH](O)C4)C(=O)Nc5cccc(c5)C(F)(F)F | InChi: | InChI=1S/C25H23F3N8O2/c1-15-5-6-16(21(38)30-18-4-2-3-17(12-18)25(26,27)28)11-20(15)31-22-32-23(35-9-7-19(37)13-35)34-24(33-22)36-10-8-29-14-36/h2-6,8,10-12,14,19,37H,7,9,13H2,1H3,(H,30,38)(H,31,32,33,34)/t19-/m1/s1 | Definition date: | 2018-12-14 | Last modified: | 2020-01-10 | Release date: | 2020-01-15 | Identifier: | 3-[[4-imidazol-1-yl-6-[(3~{R})-3-oxidanylpyrrolidin-1-yl]-1,3,5-triazin-2-yl]amino]-4-methyl-~{N}-[3-(trifluoromethyl)phenyl]benzamide |
|
![HNZ HNZ](https://data.pdbj.org/pdbjplus/data/cc/svg/HNZ.svg) | HNZ | Name: | 3-[(4-imidazol-1-yl-6-piperazin-1-yl-1,3,5-triazin-2-yl)amino]-4-methyl-~{N}-[3-(trifluoromethyl)phenyl]benzamide | Formula: | C25 H24 F3 N9 O | SMILES: | Cc1ccc(cc1Nc2nc(nc(n2)n3ccnc3)N4CCNCC4)C(=O)Nc5cccc(c5)C(F)(F)F | InChi: | InChI=1S/C25H24F3N9O/c1-16-5-6-17(21(38)31-19-4-2-3-18(14-19)25(26,27)28)13-20(16)32-22-33-23(36-10-7-29-8-11-36)35-24(34-22)37-12-9-30-15-37/h2-6,9,12-15,29H,7-8,10-11H2,1H3,(H,31,38)(H,32,33,34,35) | Definition date: | 2018-12-14 | Last modified: | 2020-01-10 | Release date: | 2020-01-15 | Identifier: | 3-[(4-imidazol-1-yl-6-piperazin-1-yl-1,3,5-triazin-2-yl)amino]-4-methyl-~{N}-[3-(trifluoromethyl)phenyl]benzamide |
|
![HO5 HO5](https://data.pdbj.org/pdbjplus/data/cc/svg/HO5.svg) | HO5 | Name: | 3-[[4-imidazol-1-yl-6-[(3~{S})-3-oxidanylpyrrolidin-1-yl]-1,3,5-triazin-2-yl]amino]-4-methyl-~{N}-[3-(trifluoromethyl)phenyl]benzamide | Formula: | C25 H23 F3 N8 O2 | SMILES: | Cc1ccc(cc1Nc2nc(nc(n2)n3ccnc3)N4CC[CH](O)C4)C(=O)Nc5cccc(c5)C(F)(F)F | InChi: | InChI=1S/C25H23F3N8O2/c1-15-5-6-16(21(38)30-18-4-2-3-17(12-18)25(26,27)28)11-20(15)31-22-32-23(35-9-7-19(37)13-35)34-24(33-22)36-10-8-29-14-36/h2-6,8,10-12,14,19,37H,7,9,13H2,1H3,(H,30,38)(H,31,32,33,34)/t19-/m0/s1 | Definition date: | 2018-12-14 | Last modified: | 2020-01-10 | Release date: | 2020-01-15 | Identifier: | 3-[[4-imidazol-1-yl-6-[(3~{S})-3-oxidanylpyrrolidin-1-yl]-1,3,5-triazin-2-yl]amino]-4-methyl-~{N}-[3-(trifluoromethyl)phenyl]benzamide |
|
![HO8 HO8](https://data.pdbj.org/pdbjplus/data/cc/svg/HO8.svg) | HO8 | Name: | 3-[(4-imidazol-1-yl-6-morpholin-4-yl-1,3,5-triazin-2-yl)amino]-4-methyl-~{N}-[3-(trifluoromethyl)phenyl]benzamide | Formula: | C25 H23 F3 N8 O2 | SMILES: | Cc1ccc(cc1Nc2nc(nc(n2)n3ccnc3)N4CCOCC4)C(=O)Nc5cccc(c5)C(F)(F)F | InChi: | InChI=1S/C25H23F3N8O2/c1-16-5-6-17(21(37)30-19-4-2-3-18(14-19)25(26,27)28)13-20(16)31-22-32-23(35-9-11-38-12-10-35)34-24(33-22)36-8-7-29-15-36/h2-8,13-15H,9-12H2,1H3,(H,30,37)(H,31,32,33,34) | Definition date: | 2018-12-14 | Last modified: | 2020-01-10 | Release date: | 2020-01-15 | Identifier: | 3-[(4-imidazol-1-yl-6-morpholin-4-yl-1,3,5-triazin-2-yl)amino]-4-methyl-~{N}-[3-(trifluoromethyl)phenyl]benzamide |
|